Recommandations en Neurologie

41 recommandations en vigueur en Neurologie émanant d’agences nationales, de sociétés savantes européennes et d’organismes d’HTA, réparties sur 12 groupes de sources. eUvidence ancre ses réponses en Neurologie sur ces recommandations ; chaque entrée renvoie à la page de l’organisme émetteur.

Sociétés savantes européennes· 5

• European Stroke Organisation (ESO) and European Association of Neurosurgical Societies (EANS) guideline on stroke due to spontaneous intracerebral haemorrhage

  ESO · European Stroke Organisation · 2025

• European Academy of Neurology (EAN) guideline on the management of amyotrophic lateral sclerosis in collaboration with European Reference Network for Neuromuscular Diseases (ERN EURO-NMD)

  EAN · European Academy of Neurology · 2024

• European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention - 2022 update

  EHF · European Headache Federation · 2022

• European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke

  ESO · European Stroke Organisation · 2021

• A European Academy of Neurology guideline on medical management issues in dementia

  EAN · European Academy of Neurology · 2020

Finlande· 2

• Epilepsy (Adults)

  Kaypa hoito · Finnish Medical Society Duodecim and the Finnish Neurological Society · 2020

• Brain Injuries

  Kaypa hoito · Finnish Medical Society Duodecim (in collaboration with multiple specialist societies) · 2017

France· 4

• Stroke: early management (alert, prehospital phase, initial hospital phase, indications for intravenous thrombolysis and mechanical thrombectomy)

  HAS · Haute Autorite de Sante · 2025 · recommendation

• Epilepsies: management of children and adults

  HAS · Haute Autorite de Sante · 2020 · recommendation

• Care pathway for patients with a neurocognitive disorder associated with Alzheimer's disease or a related disease

  HAS · Haute Autorite de Sante · 2018

• Care pathway guide: Parkinson's disease

  HAS · Haute Autorite de Sante · 2016

Allemagne· 6

• Dementias (S3 living guideline)

  DGN · Deutsche Gesellschaft fuer Neurologie / DGPPN · 2026

• Diagnosis and treatment of multiple sclerosis, neuromyelitis optica spectrum disorder and MOG-IgG-associated disease

  DGN · Deutsche Gesellschaft fuer Neurologie · 2025

• Therapy of the migraine attack and prophylaxis of migraine

  DGN · Deutsche Gesellschaft fuer Neurologie · 2024

• First epileptic seizure and epilepsies in adulthood

  DGN · Deutsche Gesellschaft fuer Neurologie · 2023

• Parkinson's disease

  DGN · Deutsche Gesellschaft fuer Neurologie · 2023

• Acute therapy of ischaemic stroke

  DGN · Deutsche Gesellschaft fuer Neurologie · 2022

Italie· 2

• Diagnosis and Treatment of Dementia and Mild Cognitive Impairment

  ISS · Istituto Superiore di Sanita · 2023

• Diagnosis and Therapy of Multiple Sclerosis in Adults

  SIN · Societa Italiana di Neurologia · 2022

Pays-Bas· 5

• Thrombolysis with alteplase in acute ischaemic stroke

  NVN · Nederlandse Vereniging voor Neurologie · 2021

• Disease-modifying treatment of multiple sclerosis

  NVN · Nederlandse Vereniging voor Neurologie · 2021

• Anti-seizure medication in epilepsy

  NVN · Nederlandse Vereniging voor Neurologie · 2020

• Pharmacological treatment of motor symptoms in Parkinson's disease

  NVN · Nederlandse Vereniging voor Neurologie · 2020

• Prophylactic treatment of migraine

  NVN · Nederlandse Vereniging voor Neurologie · 2018

Norvège· 1

• National Clinical Guideline for Treatment and Rehabilitation of Stroke

  Helsedir · Norwegian Directorate of Health · 2017

Pologne· 2

• Disease-Modifying Treatment of Multiple Sclerosis - Recommendations of the Multiple Sclerosis and Neuroimmunology Section of the Polish Neurological Society

  PTN · Polskie Towarzystwo Neurologiczne · 2023 · recommendation

• Diagnosis and Treatment of Epilepsy - Guidelines of the Epilepsy Section of the Polish Neurological Society

  PTN · Polskie Towarzystwo Neurologiczne · 2022

Portugal· 2

• Diagnostic and Therapeutic Approach to the Patient with Cognitive Decline or Dementia

  DGS · Direcao-Geral da Saude · 2023

• Stroke Green Channel in Adults

  DGS · Direcao-Geral da Saude · 2017

Espagne· 3

• Clinical Practice Guideline on the Management of Stroke in Primary Care

  GuiaSalud · Osteba (Servicio de Evaluacion de Tecnologias Sanitarias del Pais Vasco) / Ministerio de Sanidad · 2024

• Clinical Practice Guideline on Secondary Prevention of Stroke (Update)

  GuiaSalud · AETSA - Evaluacion de Tecnologias Sanitarias de Andalucia / Ministerio de Sanidad · 2023

• Clinical Practice Recommendations in Parkinson's Disease

  SAN · Sociedad Andaluza de Neurologia / Grupo Andaluz de Trastornos del Movimiento · 2022

Suède· 3

• National Guidelines for Stroke Care - Support for Governance and Management

  Socialstyrelsen · National Board of Health and Welfare · 2020

• National Guidelines for Epilepsy Care - Support for Governance and Management

  Socialstyrelsen · National Board of Health and Welfare · 2019

• Pharmacological Treatment of Multiple Sclerosis - Treatment Recommendation

  Lakemedelsverket · Medical Products Agency · 2019 · recommendation

Royaume-Uni· 6

• Epilepsies in children, young people and adults

  NICE · National Institute for Health and Care Excellence · 2022

• Multiple sclerosis in adults: management

  NICE · National Institute for Health and Care Excellence · 2022

• Stroke and transient ischaemic attack in over 16s: diagnosis and initial management

  NICE · National Institute for Health and Care Excellence · 2019

• Dementia: assessment, management and support for people living with dementia and their carers

  NICE · National Institute for Health and Care Excellence · 2018

• Parkinson's disease in adults

  NICE · National Institute for Health and Care Excellence · 2017

• Headaches in over 12s: diagnosis and management

  NICE · National Institute for Health and Care Excellence · 2012